Li, Da-Lu, et al. “Anti-Tumor Activity of Cabozantinib by FAK down-Regulation in Human Oral Squamous Cell Carcinoma”. Bangladesh Journal of Pharmacology, vol. 11, no. 1, Dec. 2015, pp. 119-25, doi:10.3329/bjp.v11i1.24001.